Table of Content

1 Point-Of-Care Or Rapid Diagnostics Market Overview
1.1 Product Overview and Scope of Point-Of-Care Or Rapid Diagnostics
1.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Point-Of-Care Or Rapid Diagnostics Segment by Application
1.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Point-Of-Care Or Rapid Diagnostics Revenue 2016-2027
1.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027
1.4.3 Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Point-Of-Care Or Rapid Diagnostics Market Competition by Manufacturers
2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Point-Of-Care Or Rapid Diagnostics Manufacturing Sites, Area Served, Product Type
2.5 Point-Of-Care Or Rapid Diagnostics Market Competitive Situation and Trends
2.5.1 Point-Of-Care Or Rapid Diagnostics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue
2.5.3 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario by Region
3.1 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.3.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Country
3.3.2 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.4.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country
3.4.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Region
3.5.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region
3.5.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.6.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country
3.6.2 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.7.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country
3.7.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Type
4.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
4.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2016-2021)
4.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2021)

5 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Application
5.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2016-2021)
5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Corporation Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Corporation Information
6.5.2 Bio-Rad Laboratories Description and Business Overview
6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments/Updates
6.6 BioMerieux
6.6.1 BioMerieux Corporation Information
6.6.2 BioMerieux Description and Business Overview
6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.6.5 BioMerieux Recent Developments/Updates
6.7 Nova Biomedical
6.6.1 Nova Biomedical Corporation Information
6.6.2 Nova Biomedical Description and Business Overview
6.6.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.7.5 Nova Biomedical Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Quidel
6.9.1 Quidel Corporation Information
6.9.2 Quidel Description and Business Overview
6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.9.5 Quidel Recent Developments/Updates
6.10 A. Menarini Diagnostics
6.10.1 A. Menarini Diagnostics Corporation Information
6.10.2 A. Menarini Diagnostics Description and Business Overview
6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.10.5 A. Menarini Diagnostics Recent Developments/Updates
6.11 Becton Dickinson
6.11.1 Becton Dickinson Corporation Information
6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments/Updates
6.12 Biosurfit
6.12.1 Biosurfit Corporation Information
6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments/Updates
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Corporation Information
6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments/Updates
6.14 Werfen
6.14.1 Werfen Corporation Information
6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments/Updates
6.15 Abionic
6.15.1 Abionic Corporation Information
6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments/Updates
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Corporation Information
6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments/Updates
6.17 Horiba Medical
6.17.1 Horiba Medical Corporation Information
6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments/Updates
6.18 RAL
6.18.1 RAL Corporation Information
6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments/Updates
6.19 Vircell
6.19.1 Vircell Corporation Information
6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments/Updates
6.20 Monlab
6.20.1 Monlab Corporation Information
6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments/Updates
6.21 Binding Site
6.21.1 Binding Site Corporation Information
6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments/Updates

7 Point-Of-Care Or Rapid Diagnostics Manufacturing Cost Analysis
7.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
7.4 Point-Of-Care Or Rapid Diagnostics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Point-Of-Care Or Rapid Diagnostics Distributors List
8.3 Point-Of-Care Or Rapid Diagnostics Customers

9 Point-Of-Care Or Rapid Diagnostics Market Dynamics
9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
9.2 Point-Of-Care Or Rapid Diagnostics Growth Drivers
9.3 Point-Of-Care Or Rapid Diagnostics Market Challenges
9.4 Point-Of-Care Or Rapid Diagnostics Market Restraints

10 Global Market Forecast
10.1 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Type (2022-2027)
10.2 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Application (2022-2027)
10.3 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Covered in This Study
Table 5. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Point-Of-Care Or Rapid Diagnostics Manufacturing Sites and Area Served
Table 11. Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Point-Of-Care Or Rapid Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-Of-Care Or Rapid Diagnostics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021) & (K Doses)
Table 16. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Table 17. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 19. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 20. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 22. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 24. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 32. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 38. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Type (2016-2021)
Table 39. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
Table 40. Global Point-Of-Care Or Rapid Diagnostics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Type (2016-2021)
Table 42. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2016-2021)
Table 43. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Application (2016-2021)
Table 44. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
Table 45. Global Point-Of-Care Or Rapid Diagnostics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Application (2016-2021)
Table 47. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. Roche Point-Of-Care Or Rapid Diagnostics Product
Table 52. Roche Recent Developments/Updates
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Business Overview
Table 55. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. Abbott Point-Of-Care Or Rapid Diagnostics Product
Table 57. Abbott Recent Developments/Updates
Table 58. Danaher Corporation Information
Table 59. Danaher Description and Business Overview
Table 60. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. Danaher Point-Of-Care Or Rapid Diagnostics Product
Table 62. Danaher Recent Developments/Updates
Table 63. Siemens Healthcare Corporation Information
Table 64. Siemens Healthcare Description and Business Overview
Table 65. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 66. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product
Table 67. Siemens Healthcare Recent Developments/Updates
Table 68. Bio-Rad Laboratories Corporation Information
Table 69. Bio-Rad Laboratories Description and Business Overview
Table 70. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 71. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product
Table 72. Bio-Rad Laboratories Recent Developments/Updates
Table 73. BioMerieux Corporation Information
Table 74. BioMerieux Description and Business Overview
Table 75. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 76. BioMerieux Point-Of-Care Or Rapid Diagnostics Product
Table 77. BioMerieux Recent Developments/Updates
Table 78. Nova Biomedical Corporation Information
Table 79. Nova Biomedical Description and Business Overview
Table 80. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 81. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product
Table 82. Nova Biomedical Recent Developments/Updates
Table 83. Thermo Fisher Scientific Corporation Information
Table 84. Thermo Fisher Scientific Description and Business Overview
Table 85. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 86. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product
Table 87. Thermo Fisher Scientific Recent Developments/Updates
Table 88. Quidel Corporation Information
Table 89. Quidel Description and Business Overview
Table 90. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 91. Quidel Point-Of-Care Or Rapid Diagnostics Product
Table 92. Quidel Recent Developments/Updates
Table 93. A. Menarini Diagnostics Corporation Information
Table 94. A. Menarini Diagnostics Description and Business Overview
Table 95. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 96. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 97. A. Menarini Diagnostics Recent Developments/Updates
Table 98. Becton Dickinson Corporation Information
Table 99. Becton Dickinson Description and Business Overview
Table 100. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 101. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product
Table 102. Becton Dickinson Recent Developments/Updates
Table 103. Biosurfit Corporation Information
Table 104. Biosurfit Description and Business Overview
Table 105. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 106. Biosurfit Point-Of-Care Or Rapid Diagnostics Product
Table 107. Biosurfit Recent Developments/Updates
Table 108. Astrego Diagnostics Corporation Information
Table 109. Astrego Diagnostics Description and Business Overview
Table 110. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 111. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 112. Astrego Diagnostics Recent Developments/Updates
Table 113. Werfen Corporation Information
Table 114. Werfen Description and Business Overview
Table 115. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 116. Werfen Point-Of-Care Or Rapid Diagnostics Product
Table 117. Werfen Recent Developments/Updates
Table 118. Abionic Corporation Information
Table 119. Abionic Description and Business Overview
Table 120. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 121. Abionic Point-Of-Care Or Rapid Diagnostics Product
Table 122. Abionic Recent Developments/Updates
Table 123. Palex Medical/Bülhmann Corporation Information
Table 124. Palex Medical/Bülhmann Description and Business Overview
Table 125. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 126. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product
Table 127. Palex Medical/Bülhmann Recent Developments/Updates
Table 128. Horiba Medical Corporation Information
Table 129. Horiba Medical Description and Business Overview
Table 130. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 131. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product
Table 132. Horiba Medical Recent Developments/Updates
Table 133. RAL Corporation Information
Table 134. RAL Description and Business Overview
Table 135. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 136. RAL Point-Of-Care Or Rapid Diagnostics Product
Table 137. RAL Recent Developments/Updates
Table 138. Vircell Corporation Information
Table 139. Vircell Description and Business Overview
Table 140. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 141. Vircell Point-Of-Care Or Rapid Diagnostics Product
Table 142. Vircell Recent Developments/Updates
Table 143. Monlab Corporation Information
Table 144. Monlab Description and Business Overview
Table 145. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 146. Monlab Point-Of-Care Or Rapid Diagnostics Product
Table 147. Monlab Recent Developments/Updates
Table 148. Binding Site Corporation Information
Table 149. Binding Site Description and Business Overview
Table 150. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 151. Binding Site Point-Of-Care Or Rapid Diagnostics Product
Table 152. Binding Site Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 156. Point-Of-Care Or Rapid Diagnostics Customers List
Table 157. Point-Of-Care Or Rapid Diagnostics Market Trends
Table 158. Point-Of-Care Or Rapid Diagnostics Growth Drivers
Table 159. Point-Of-Care Or Rapid Diagnostics Market Challenges
Table 160. Point-Of-Care Or Rapid Diagnostics Market Restraints
Table 161. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2022-2027) & (K Doses)
Table 162. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2022-2027) & (K Doses)
Table 166. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2022-2027) & (K Doses)
Table 170. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Point-Of-Care Or Rapid Diagnostics
Figure 2. Global Point-Of-Care Or Rapid Diagnostics Market Share by Type in 2020 & 2027
Figure 3. Intensive Care Product Picture
Figure 4. Covid-19 Testing Product Picture
Figure 5. Infectious Diseases Testing Product Picture
Figure 6. Cardiac Markers Testing Product Picture
Figure 7. Coagulation Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Point-Of-Care Or Rapid Diagnostics Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Independent Laboratories
Figure 13. Others
Figure 14. Global Point-Of-Care Or Rapid Diagnostics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Point-Of-Care Or Rapid Diagnostics Market Size 2016-2027 (US$ Million)
Figure 16. Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027 (K Doses)
Figure 17. Global Point-Of-Care Or Rapid Diagnostics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Point-Of-Care Or Rapid Diagnostics Sales Share by Manufacturers in 2020
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Point-Of-Care Or Rapid Diagnostics Players: Market Share by Revenue in 2020
Figure 21. Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Figure 23. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2020
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Figure 25. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region in 2020
Figure 26. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. China Taiwan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Point-Of-Care Or Rapid Diagnostics by Type (2016-2021)
Figure 49. Sales Market Share of Point-Of-Care Or Rapid Diagnostics by Application (2016-2021)
Figure 50. Sales Market Share of Point-Of-Care Or Rapid Diagnostics by Application in 2020
Figure 51. Revenue Share of Point-Of-Care Or Rapid Diagnostics by Application (2016-2021)
Figure 52. Revenue Share of Point-Of-Care Or Rapid Diagnostics by Application in 2020
Figure 53. Manufacturing Cost Structure of Point-Of-Care Or Rapid Diagnostics
Figure 54. Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
Figure 55. Point-Of-Care Or Rapid Diagnostics Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed